GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:ATHJF) » Definitions » Minority Interest

Percheron Therapeutics (Percheron Therapeutics) Minority Interest : $0.00 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Percheron Therapeutics Minority Interest?

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Percheron Therapeutics's minority interest for the quarter that ended in Dec. 2023 was $0.00 Mil.

Percheron Therapeutics Minority Interest Historical Data

The historical data trend for Percheron Therapeutics's Minority Interest can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Percheron Therapeutics Minority Interest Chart

Percheron Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Minority Interest
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Percheron Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Minority Interest Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Percheron Therapeutics Minority Interest Calculation

Minority interest is the carrying amount of the equity interests owned by non-controlling shareholders, partners, or other equity holders in one or more of the entities included in the reporting entity's consolidated financial statements.

Percheron Therapeutics (Percheron Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (OTCPK:ATHJF) » Definitions » Minority Interest
Comparable Companies
ASX:VIT ASX:MVP ASX:IVX ASX:LGP ASX:IDT ASX:LV1 ASX:ECS ASX:CAN ASX:EOF ASX:NXS ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
AWY0:Germany PER:Australia
Address
14 Wallace Avenue, Toorak, VIC, AUS, 3142
Website
https://www.antisense.com.au
Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals. The company operates in two segments that have been identified based on its antisense oligonucleotide products as ATL1102 and ATL1103.